

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.43136249 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.43136249 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.15479320 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.15479320 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.77111090 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.20854120 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.20854120 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.20854120 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19164723 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.03849588 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.90067145 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.82175879 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.73298264 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.61630331 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56199711 |
| 16 | urea cycle (GO:0000050) | 5.52262625 |
| 17 | urea metabolic process (GO:0019627) | 5.52262625 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.49369086 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.45013383 |
| 20 | protein carboxylation (GO:0018214) | 5.37547803 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37547803 |
| 22 | cysteine metabolic process (GO:0006534) | 5.33459771 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.32707680 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.30171134 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.28735341 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 5.08095555 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.07883652 |
| 28 | bile acid metabolic process (GO:0008206) | 5.00539659 |
| 29 | regulation of complement activation (GO:0030449) | 4.94279896 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94071312 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 4.91345953 |
| 32 | coenzyme catabolic process (GO:0009109) | 4.87324817 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.75539687 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.75009848 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.73913602 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.69092724 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.67100736 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.67100736 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.67100736 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.63782052 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.59575405 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.54793478 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.53029617 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.53029617 |
| 45 | cellular modified amino acid catabolic process (GO:0042219) | 4.48631881 |
| 46 | phospholipid efflux (GO:0033700) | 4.47072342 |
| 47 | lysine catabolic process (GO:0006554) | 4.46677230 |
| 48 | lysine metabolic process (GO:0006553) | 4.46677230 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.46239822 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.46239822 |
| 51 | glycine metabolic process (GO:0006544) | 4.41345780 |
| 52 | negative regulation of protein activation cascade (GO:2000258) | 4.37913938 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.37305451 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.31540597 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 4.30593400 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 4.30087851 |
| 57 | cellular biogenic amine catabolic process (GO:0042402) | 4.30049465 |
| 58 | amine catabolic process (GO:0009310) | 4.30049465 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 4.29393036 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.23235288 |
| 61 | exogenous drug catabolic process (GO:0042738) | 4.22195507 |
| 62 | serine family amino acid metabolic process (GO:0009069) | 4.16587187 |
| 63 | cellular glucuronidation (GO:0052695) | 4.14702025 |
| 64 | epoxygenase P450 pathway (GO:0019373) | 4.12751243 |
| 65 | benzene-containing compound metabolic process (GO:0042537) | 4.09357809 |
| 66 | cholesterol efflux (GO:0033344) | 4.08964852 |
| 67 | ethanol oxidation (GO:0006069) | 4.06054014 |
| 68 | glutamate metabolic process (GO:0006536) | 4.04761837 |
| 69 | cofactor catabolic process (GO:0051187) | 4.02876926 |
| 70 | negative regulation of complement activation (GO:0045916) | 4.01720031 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 4.01209644 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 4.01101624 |
| 73 | fibrinolysis (GO:0042730) | 3.93894778 |
| 74 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91815416 |
| 75 | arginine metabolic process (GO:0006525) | 3.90521738 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 3.88312627 |
| 77 | blood coagulation, intrinsic pathway (GO:0007597) | 3.88126028 |
| 78 | omega-hydroxylase P450 pathway (GO:0097267) | 3.86469981 |
| 79 | regulation of humoral immune response (GO:0002920) | 3.85961334 |
| 80 | aldehyde catabolic process (GO:0046185) | 3.85810969 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80778059 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74947094 |
| 83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74947094 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.74896313 |
| 85 | organic acid catabolic process (GO:0016054) | 3.74896313 |
| 86 | regulation of apoptotic cell clearance (GO:2000425) | 3.72613653 |
| 87 | acute-phase response (GO:0006953) | 3.72019478 |
| 88 | cytolysis (GO:0019835) | 3.69799390 |
| 89 | drug catabolic process (GO:0042737) | 3.69726942 |
| 90 | regulation of plasminogen activation (GO:0010755) | 3.68387437 |
| 91 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67626706 |
| 92 | glucuronate metabolic process (GO:0019585) | 3.66468538 |
| 93 | uronic acid metabolic process (GO:0006063) | 3.66468538 |
| 94 | negative regulation of humoral immune response (GO:0002921) | 3.65624694 |
| 95 | ketone body metabolic process (GO:1902224) | 3.65490641 |
| 96 | heme transport (GO:0015886) | 3.64790674 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.64618554 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.64445745 |
| 99 | detection of external biotic stimulus (GO:0098581) | 3.63808828 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.63416816 |
| 101 | * protein activation cascade (GO:0072376) | 3.63221509 |
| 102 | short-chain fatty acid metabolic process (GO:0046459) | 3.62378566 |
| 103 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.62229726 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.59582268 |
| 105 | sterol homeostasis (GO:0055092) | 3.58776854 |
| 106 | NAD biosynthetic process (GO:0009435) | 3.58138577 |
| 107 | * complement activation, classical pathway (GO:0006958) | 3.57507320 |
| 108 | * complement activation (GO:0006956) | 3.57177338 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.55978323 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.55590366 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.55136016 |
| 112 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54999665 |
| 113 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.54999665 |
| 114 | detection of other organism (GO:0098543) | 3.48855562 |
| 115 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47354982 |
| 116 | detection of bacterium (GO:0016045) | 3.37762420 |
| 117 | opsonization (GO:0008228) | 3.37219303 |
| 118 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35451194 |
| 119 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.33266661 |
| 120 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.33266661 |
| 121 | ethanol metabolic process (GO:0006067) | 3.32440804 |
| 122 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.30160940 |
| 123 | positive regulation of blood coagulation (GO:0030194) | 3.22316565 |
| 124 | positive regulation of hemostasis (GO:1900048) | 3.22316565 |
| 125 | detection of biotic stimulus (GO:0009595) | 3.17398362 |
| 126 | negative regulation of hemostasis (GO:1900047) | 3.16522253 |
| 127 | negative regulation of blood coagulation (GO:0030195) | 3.16522253 |
| 128 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.09037167 |
| 129 | modulation by symbiont of host defense response (GO:0052031) | 3.06129636 |
| 130 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.06129636 |
| 131 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.06129636 |
| 132 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.06129636 |
| 133 | modulation by symbiont of host immune response (GO:0052553) | 3.06129636 |
| 134 | positive regulation by symbiont of host defense response (GO:0052509) | 3.06129636 |
| 135 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.05005450 |
| 136 | negative regulation of cell killing (GO:0031342) | 3.05005450 |
| 137 | positive regulation of coagulation (GO:0050820) | 2.95541864 |
| 138 | negative regulation of coagulation (GO:0050819) | 2.88302832 |
| 139 | acute inflammatory response (GO:0002526) | 2.88036338 |
| 140 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85936210 |
| 141 | negative regulation of wound healing (GO:0061045) | 2.82422623 |
| 142 | intestinal cholesterol absorption (GO:0030299) | 2.81108278 |
| 143 | drug metabolic process (GO:0017144) | 2.80956818 |
| 144 | positive regulation of extracellular matrix organization (GO:1903055) | 2.76869485 |
| 145 | macrophage activation involved in immune response (GO:0002281) | 2.74743545 |
| 146 | regulation of acute inflammatory response (GO:0002673) | 2.74523043 |
| 147 | hormone catabolic process (GO:0042447) | 2.72324761 |
| 148 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.67823047 |
| 149 | response to mercury ion (GO:0046689) | 2.66088467 |
| 150 | cellular extravasation (GO:0045123) | 2.65987304 |
| 151 | negative regulation of B cell mediated immunity (GO:0002713) | 2.60678501 |
| 152 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.60678501 |
| 153 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58443229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31051349 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.15510660 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.95965824 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38860969 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29923644 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.05100422 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.93999636 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06224657 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02307437 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7521623 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96938794 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92785260 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92407805 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87556726 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.85886142 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85612269 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.83556067 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.82843102 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82248335 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81756259 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79193167 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77861759 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71015123 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70364394 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69649601 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67647752 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51144914 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50072484 |
| 29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49084148 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46782227 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46318934 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42723079 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42480422 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41396411 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.40658318 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39974761 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39289913 |
| 38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38949253 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38535058 |
| 40 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37815498 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36620883 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36446157 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35431045 |
| 44 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34419855 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33519206 |
| 46 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30220294 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29615280 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29216261 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27962852 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27092818 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23509852 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16130925 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15579530 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.14895727 |
| 55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12614202 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11202973 |
| 57 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09470845 |
| 58 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08686772 |
| 59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07392099 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06478452 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06301425 |
| 62 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05291204 |
| 63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04937148 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04149417 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03631287 |
| 66 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03556724 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03405129 |
| 68 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03130453 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.01889027 |
| 70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97955486 |
| 71 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97882184 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96200794 |
| 73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95294575 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 0.94378804 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93547702 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93468249 |
| 77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93397932 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92626128 |
| 79 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92424162 |
| 80 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92134069 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92095703 |
| 82 | MYC_22102868_ChIP-Seq_BL_Human | 0.91205456 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90797630 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90745810 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90487449 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90011863 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89461819 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88064453 |
| 89 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87779855 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86515115 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84971044 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84117104 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81509754 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81342629 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79960843 |
| 96 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78723281 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78567167 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77293187 |
| 99 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.76268451 |
| 100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.76268451 |
| 101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.76268451 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75807332 |
| 103 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75749541 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73065189 |
| 105 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72951829 |
| 106 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71968956 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71289742 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71146198 |
| 109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69241234 |
| 110 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68810150 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68584883 |
| 112 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67692772 |
| 113 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.63668179 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61700266 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.61577067 |
| 116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.60356641 |
| 117 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57521750 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56964053 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56453585 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.55913968 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55721163 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55721163 |
| 123 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.54989823 |
| 124 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.54475447 |
| 125 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51283759 |
| 126 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.50975739 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50094965 |
| 128 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49333422 |
| 129 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48628606 |
| 130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.48429863 |
| 131 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.48194862 |
| 132 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48079492 |
| 133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.47844415 |
| 134 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.46656523 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.46115003 |
| 136 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45814000 |
| 137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45580486 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44433624 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.44188247 |
| 140 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.43646494 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43358076 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43256389 |
| 143 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.42927333 |
| 144 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.42146903 |
| 145 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.41829862 |
| 146 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.41413964 |
| 147 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.40879408 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40755064 |
| 149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.39763746 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.39746863 |
| 151 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39614007 |
| 152 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.39508144 |
| 153 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.39031946 |
| 154 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.38738048 |
| 155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38525699 |
| 156 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.38468660 |
| 157 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.38314259 |
| 158 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.37913807 |
| 159 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37632746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.11387648 |
| 2 | MP0005360_urolithiasis | 7.34986481 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.34244418 |
| 4 | MP0005365_abnormal_bile_salt | 6.16441980 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.94116882 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.18920190 |
| 7 | MP0003252_abnormal_bile_duct | 3.80758455 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.50298014 |
| 9 | MP0009840_abnormal_foam_cell | 3.14616254 |
| 10 | MP0005083_abnormal_biliary_tract | 3.14567821 |
| 11 | MP0005332_abnormal_amino_acid | 2.72229519 |
| 12 | MP0003195_calcinosis | 2.68432636 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.65735926 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.35453268 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.19057016 |
| 16 | MP0000609_abnormal_liver_physiology | 2.17743366 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.09387684 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.05719255 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 2.00490391 |
| 20 | MP0002419_abnormal_innate_immunity | 1.99689713 |
| 21 | MP0003868_abnormal_feces_composition | 1.93435963 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.92944021 |
| 23 | MP0003011_delayed_dark_adaptation | 1.91887439 |
| 24 | MP0003303_peritoneal_inflammation | 1.91585013 |
| 25 | MP0000685_abnormal_immune_system | 1.89993252 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.84088915 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.83328317 |
| 28 | MP0005025_abnormal_response_to | 1.79199274 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.68462090 |
| 30 | MP0001764_abnormal_homeostasis | 1.64081395 |
| 31 | MP0001958_emphysema | 1.63483779 |
| 32 | MP0001790_abnormal_immune_system | 1.55097434 |
| 33 | MP0005387_immune_system_phenotype | 1.55097434 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55087131 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.53910029 |
| 36 | MP0009697_abnormal_copulation | 1.50655443 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.47549085 |
| 38 | MP0001800_abnormal_humoral_immune | 1.44187293 |
| 39 | MP0002254_reproductive_system_inflammat | 1.42126966 |
| 40 | MP0003186_abnormal_redox_activity | 1.41293048 |
| 41 | MP0005451_abnormal_body_composition | 1.37958169 |
| 42 | MP0000858_altered_metastatic_potential | 1.35036120 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.34729937 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.34046509 |
| 45 | MP0002933_joint_inflammation | 1.33500679 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.32091325 |
| 47 | MP0005023_abnormal_wound_healing | 1.29937443 |
| 48 | MP0002405_respiratory_system_inflammati | 1.24938293 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.24750708 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.24284587 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.23567573 |
| 52 | MP0003279_aneurysm | 1.22847027 |
| 53 | MP0002723_abnormal_immune_serum | 1.22548905 |
| 54 | MP0000598_abnormal_liver_morphology | 1.22076684 |
| 55 | MP0005647_abnormal_sex_gland | 1.19816115 |
| 56 | MP0009764_decreased_sensitivity_to | 1.17631027 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.15129226 |
| 58 | MP0008260_abnormal_autophagy | 1.14123130 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.13674106 |
| 60 | MP0003828_pulmonary_edema | 1.13542412 |
| 61 | MP0001851_eye_inflammation | 1.12918643 |
| 62 | MP0006054_spinal_hemorrhage | 1.10734474 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.08879118 |
| 64 | MP0005503_abnormal_tendon_morphology | 1.08685942 |
| 65 | MP0005275_abnormal_skin_tensile | 1.08362465 |
| 66 | MP0001819_abnormal_immune_cell | 1.08178136 |
| 67 | MP0009763_increased_sensitivity_to | 1.05510098 |
| 68 | MP0010368_abnormal_lymphatic_system | 1.04889513 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.04572430 |
| 70 | MP0004947_skin_inflammation | 1.03070886 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 0.99933497 |
| 72 | MP0008469_abnormal_protein_level | 0.97257856 |
| 73 | MP0001915_intracranial_hemorrhage | 0.97214372 |
| 74 | MP0004858_abnormal_nervous_system | 0.94502491 |
| 75 | MP0004272_abnormal_basement_membrane | 0.93966424 |
| 76 | MP0000767_abnormal_smooth_muscle | 0.92276366 |
| 77 | MP0003091_abnormal_cell_migration | 0.91942456 |
| 78 | MP0008004_abnormal_stomach_pH | 0.91800640 |
| 79 | MP0005409_darkened_coat_color | 0.90517141 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.90094312 |
| 81 | MP0005670_abnormal_white_adipose | 0.89887820 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.89723332 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.89308497 |
| 84 | MP0000604_amyloidosis | 0.89188263 |
| 85 | MP0005390_skeleton_phenotype | 0.87564755 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.85821200 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.84573065 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.84552814 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.84552814 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.83544686 |
| 91 | MP0002166_altered_tumor_susceptibility | 0.83521299 |
| 92 | MP0003763_abnormal_thymus_physiology | 0.82948362 |
| 93 | MP0003045_fibrosis | 0.82024415 |
| 94 | MP0003866_abnormal_defecation | 0.80698598 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.80350212 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.80135041 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.79791869 |
| 98 | MP0009278_abnormal_bone_marrow | 0.78807589 |
| 99 | MP0005408_hypopigmentation | 0.78551827 |
| 100 | MP0005220_abnormal_exocrine_pancreas | 0.78515909 |
| 101 | MP0000716_abnormal_immune_system | 0.77783351 |
| 102 | MP0009333_abnormal_splenocyte_physiolog | 0.75435663 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.74671251 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.73799580 |
| 105 | MP0003436_decreased_susceptibility_to | 0.71643861 |
| 106 | MP0005266_abnormal_metabolism | 0.71485193 |
| 107 | MP0005334_abnormal_fat_pad | 0.68865492 |
| 108 | MP0002971_abnormal_brown_adipose | 0.67446475 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.64024952 |
| 110 | MP0006082_CNS_inflammation | 0.63443972 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.63253580 |
| 112 | MP0004381_abnormal_hair_follicle | 0.62708793 |
| 113 | MP0003724_increased_susceptibility_to | 0.62665387 |
| 114 | MP0005535_abnormal_body_temperature | 0.61730976 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.60736087 |
| 116 | MP0005464_abnormal_platelet_physiology | 0.59322112 |
| 117 | MP0003690_abnormal_glial_cell | 0.59272087 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.58571148 |
| 119 | MP0005448_abnormal_energy_balance | 0.54803866 |
| 120 | MP0001661_extended_life_span | 0.54481646 |
| 121 | MP0004130_abnormal_muscle_cell | 0.54255970 |
| 122 | MP0001756_abnormal_urination | 0.54126224 |
| 123 | MP0002132_abnormal_respiratory_system | 0.53690975 |
| 124 | MP0009053_abnormal_anal_canal | 0.50346121 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.49423010 |
| 126 | MP0002928_abnormal_bile_duct | 0.47852671 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.47092718 |
| 128 | MP0008873_increased_physiological_sensi | 0.45935702 |
| 129 | MP0003075_altered_response_to | 0.45128359 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.45077599 |
| 131 | MP0009115_abnormal_fat_cell | 0.42780104 |
| 132 | MP0005395_other_phenotype | 0.42518677 |
| 133 | MP0008874_decreased_physiological_sensi | 0.41938213 |
| 134 | MP0002970_abnormal_white_adipose | 0.41881696 |
| 135 | MP0001853_heart_inflammation | 0.41486137 |
| 136 | MP0004883_abnormal_blood_vessel | 0.39133919 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.38434712 |
| 138 | MP0000249_abnormal_blood_vessel | 0.37170531 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.36934120 |
| 140 | MP0003953_abnormal_hormone_level | 0.36865889 |
| 141 | MP0005166_decreased_susceptibility_to | 0.36610529 |
| 142 | MP0003718_maternal_effect | 0.36073997 |
| 143 | MP0001243_abnormal_dermal_layer | 0.35573156 |
| 144 | MP0002796_impaired_skin_barrier | 0.35510234 |
| 145 | MP0003329_amyloid_beta_deposits | 0.34943255 |
| 146 | MP0008872_abnormal_physiological_respon | 0.33866060 |
| 147 | MP0005164_abnormal_response_to | 0.32142656 |
| 148 | MP0002332_abnormal_exercise_endurance | 0.28936910 |
| 149 | MP0009785_altered_susceptibility_to | 0.28891779 |
| 150 | MP0009384_cardiac_valve_regurgitation | 0.28280227 |
| 151 | MP0009672_abnormal_birth_weight | 0.26983711 |
| 152 | MP0002168_other_aberrant_phenotype | 0.26919551 |
| 153 | MP0001881_abnormal_mammary_gland | 0.26716815 |
| 154 | MP0002060_abnormal_skin_morphology | 0.26654228 |
| 155 | MP0002135_abnormal_kidney_morphology | 0.25809265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.31387682 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.22013131 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.20960699 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.50924154 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.50397680 |
| 6 | Xanthomatosis (HP:0000991) | 6.14152061 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.10869023 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.42193997 |
| 9 | Complement deficiency (HP:0004431) | 5.38238707 |
| 10 | Joint hemorrhage (HP:0005261) | 4.97526226 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.63206178 |
| 12 | Hyperammonemia (HP:0001987) | 4.56756722 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.44681259 |
| 14 | Hyperglycinemia (HP:0002154) | 4.43547664 |
| 15 | Epidermoid cyst (HP:0200040) | 4.26191885 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.24476337 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 4.22199707 |
| 18 | Ketosis (HP:0001946) | 4.21843654 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.19205706 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.17245723 |
| 21 | Fat malabsorption (HP:0002630) | 4.13067636 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.12108809 |
| 23 | Hyperglycinuria (HP:0003108) | 4.10783337 |
| 24 | Myositis (HP:0100614) | 4.09670264 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.02774219 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 4.01190263 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.01190263 |
| 28 | Abnormality of complement system (HP:0005339) | 4.00219476 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.98380755 |
| 30 | Orchitis (HP:0100796) | 3.88848218 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80673515 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.79060411 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 3.76356026 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.65311538 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63636778 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.54541525 |
| 37 | Peritonitis (HP:0002586) | 3.48919277 |
| 38 | Optic neuritis (HP:0100653) | 3.34661406 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 3.34661406 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31400227 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30857805 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.30501698 |
| 43 | Steatorrhea (HP:0002570) | 3.19323062 |
| 44 | Delayed CNS myelination (HP:0002188) | 3.12126764 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.08879651 |
| 46 | Protrusio acetabuli (HP:0003179) | 3.03021481 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 3.01507309 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 3.01054097 |
| 49 | Ketoacidosis (HP:0001993) | 2.99805572 |
| 50 | Myocardial infarction (HP:0001658) | 2.97708690 |
| 51 | Spontaneous abortion (HP:0005268) | 2.94475046 |
| 52 | Skin nodule (HP:0200036) | 2.91617183 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.89301567 |
| 54 | Recurrent abscess formation (HP:0002722) | 2.86137481 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.85177240 |
| 56 | Metabolic acidosis (HP:0001942) | 2.83063502 |
| 57 | Purpura (HP:0000979) | 2.80791236 |
| 58 | Pulmonary embolism (HP:0002204) | 2.74955272 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.72982719 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.71668152 |
| 61 | Epistaxis (HP:0000421) | 2.69906509 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.64379691 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64379691 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.64261799 |
| 65 | Gout (HP:0001997) | 2.63940146 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62440463 |
| 67 | Lethargy (HP:0001254) | 2.56120046 |
| 68 | Gingivitis (HP:0000230) | 2.55992683 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.53547475 |
| 70 | Vascular calcification (HP:0004934) | 2.52724376 |
| 71 | Aortic aneurysm (HP:0004942) | 2.51234864 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.48327225 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.47580962 |
| 74 | Malnutrition (HP:0004395) | 2.46079120 |
| 75 | Amyloidosis (HP:0011034) | 2.44477630 |
| 76 | Glomerulonephritis (HP:0000099) | 2.44339073 |
| 77 | Hypochromic anemia (HP:0001931) | 2.43242792 |
| 78 | Gingival bleeding (HP:0000225) | 2.40574646 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 2.36603397 |
| 80 | Spastic diplegia (HP:0001264) | 2.35973418 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.35779625 |
| 82 | Irritability (HP:0000737) | 2.35330892 |
| 83 | Acanthocytosis (HP:0001927) | 2.34288866 |
| 84 | Cholelithiasis (HP:0001081) | 2.31350510 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.29926426 |
| 86 | Menorrhagia (HP:0000132) | 2.28343142 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26828584 |
| 88 | Mucopolysacchariduria (HP:0008155) | 2.26828584 |
| 89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.26285329 |
| 90 | Vascular tortuosity (HP:0004948) | 2.25379662 |
| 91 | Polycythemia (HP:0001901) | 2.24889519 |
| 92 | Keratoconjunctivitis (HP:0001096) | 2.23936044 |
| 93 | Meningitis (HP:0001287) | 2.23382267 |
| 94 | Cardiovascular calcification (HP:0011915) | 2.23295519 |
| 95 | Mitral stenosis (HP:0001718) | 2.23262042 |
| 96 | Pancreatitis (HP:0001733) | 2.22344701 |
| 97 | Arterial thrombosis (HP:0004420) | 2.21810656 |
| 98 | Cerebral edema (HP:0002181) | 2.20271703 |
| 99 | Neonatal onset (HP:0003623) | 2.19783481 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 2.18829828 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18280587 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18280587 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18280587 |
| 104 | Cholecystitis (HP:0001082) | 2.17766584 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 2.17766584 |
| 106 | Enlarged kidneys (HP:0000105) | 2.16545195 |
| 107 | Hemoptysis (HP:0002105) | 2.14678525 |
| 108 | Esophageal varix (HP:0002040) | 2.14410292 |
| 109 | Vomiting (HP:0002013) | 2.12788626 |
| 110 | Cervical subluxation (HP:0003308) | 2.12383281 |
| 111 | Generalized aminoaciduria (HP:0002909) | 2.11801254 |
| 112 | Increased IgE level (HP:0003212) | 2.11098802 |
| 113 | Arterial tortuosity (HP:0005116) | 2.11072387 |
| 114 | Thrombophlebitis (HP:0004418) | 2.10540956 |
| 115 | Aortic dissection (HP:0002647) | 2.08632391 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 2.05785934 |
| 117 | Vasculitis (HP:0002633) | 2.03506613 |
| 118 | Brushfield spots (HP:0001088) | 2.03427582 |
| 119 | Recurrent skin infections (HP:0001581) | 2.02582830 |
| 120 | Abnormality of the peritoneum (HP:0002585) | 2.02463735 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 2.02077607 |
| 122 | Opisthotonus (HP:0002179) | 2.00341830 |
| 123 | Hemorrhage of the eye (HP:0011885) | 1.99579344 |
| 124 | Late onset (HP:0003584) | 1.99564819 |
| 125 | Gangrene (HP:0100758) | 1.99446073 |
| 126 | Rickets (HP:0002748) | 1.98744451 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98195799 |
| 128 | Obstructive lung disease (HP:0006536) | 1.95859718 |
| 129 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95859718 |
| 130 | Acne (HP:0001061) | 1.94733294 |
| 131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94036745 |
| 132 | Pulmonary infiltrates (HP:0002113) | 1.92923696 |
| 133 | Increased serum ferritin (HP:0003281) | 1.92681956 |
| 134 | Abnormality of the gallbladder (HP:0005264) | 1.90885589 |
| 135 | Abnormal platelet volume (HP:0011876) | 1.90782325 |
| 136 | Joint swelling (HP:0001386) | 1.90155457 |
| 137 | Aneurysm (HP:0002617) | 1.89608264 |
| 138 | Cerebral aneurysm (HP:0004944) | 1.89551696 |
| 139 | Recurrent fungal infections (HP:0002841) | 1.89367068 |
| 140 | Hypertriglyceridemia (HP:0002155) | 1.89208744 |
| 141 | Cellulitis (HP:0100658) | 1.87116102 |
| 142 | Episodic fever (HP:0001954) | 1.86859965 |
| 143 | Anorexia (HP:0002039) | 1.86071202 |
| 144 | Status epilepticus (HP:0002133) | 1.86061429 |
| 145 | Poikilocytosis (HP:0004447) | 1.83565998 |
| 146 | Elevated hepatic transaminases (HP:0002910) | 1.82167204 |
| 147 | Renal cortical cysts (HP:0000803) | 1.81930231 |
| 148 | Dilatation of the ascending aorta (HP:0005111) | 1.80818165 |
| 149 | Hydroxyprolinuria (HP:0003080) | 1.76760398 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 1.76760398 |
| 151 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76453172 |
| 152 | Elevated alkaline phosphatase (HP:0003155) | 1.75710497 |
| 153 | Interstitial pulmonary disease (HP:0006530) | 1.75523597 |
| 154 | Dysostosis multiplex (HP:0000943) | 1.75190950 |
| 155 | Upper motor neuron abnormality (HP:0002127) | 1.75145567 |
| 156 | Polygenic inheritance (HP:0010982) | 1.74305565 |
| 157 | Nephritis (HP:0000123) | 1.73444684 |
| 158 | Hyperuricemia (HP:0002149) | 1.73315751 |
| 159 | Increased purine levels (HP:0004368) | 1.73315751 |
| 160 | Abnormal platelet function (HP:0011869) | 1.72964200 |
| 161 | Impaired platelet aggregation (HP:0003540) | 1.72964200 |
| 162 | Mediastinal lymphadenopathy (HP:0100721) | 1.72208721 |
| 163 | Vertebral compression fractures (HP:0002953) | 1.71835097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.72192151 |
| 2 | ERN1 | 6.04012044 |
| 3 | SIK1 | 3.99509277 |
| 4 | FGFR4 | 3.85975939 |
| 5 | TAOK3 | 2.90040796 |
| 6 | INSRR | 2.56865940 |
| 7 | RIPK4 | 2.33804543 |
| 8 | ERBB4 | 2.30567311 |
| 9 | GRK6 | 2.22108709 |
| 10 | MAP4K1 | 2.14023362 |
| 11 | MAP2K4 | 2.13001860 |
| 12 | PRPF4B | 1.84015377 |
| 13 | FLT3 | 1.79889419 |
| 14 | PKN2 | 1.79111572 |
| 15 | TGFBR2 | 1.78899824 |
| 16 | TNK2 | 1.70050540 |
| 17 | IRAK4 | 1.67917720 |
| 18 | MST1R | 1.67220560 |
| 19 | CDK12 | 1.67185051 |
| 20 | PIK3CG | 1.65563639 |
| 21 | GRK1 | 1.64523805 |
| 22 | MAPK11 | 1.57452888 |
| 23 | CSF1R | 1.56260405 |
| 24 | TYK2 | 1.55011883 |
| 25 | TRIB3 | 1.49860071 |
| 26 | FES | 1.49393337 |
| 27 | MAP3K6 | 1.47675016 |
| 28 | JAK3 | 1.47506611 |
| 29 | ABL2 | 1.35421337 |
| 30 | PRKD2 | 1.34097909 |
| 31 | MAP3K1 | 1.32200330 |
| 32 | LATS1 | 1.30758795 |
| 33 | GRK5 | 1.30343434 |
| 34 | CDC42BPA | 1.25081075 |
| 35 | NEK9 | 1.23588551 |
| 36 | MAPK7 | 1.23295746 |
| 37 | MARK2 | 1.18685666 |
| 38 | MAP3K7 | 1.17397265 |
| 39 | MAP3K10 | 1.16287768 |
| 40 | SMG1 | 1.15102468 |
| 41 | IRAK3 | 1.12808280 |
| 42 | PTK6 | 1.12335871 |
| 43 | HCK | 1.11482621 |
| 44 | JAK2 | 1.10543102 |
| 45 | MAP3K2 | 1.09758298 |
| 46 | ADRBK2 | 1.09109347 |
| 47 | MAP2K3 | 1.06821876 |
| 48 | KDR | 1.06125506 |
| 49 | MAP3K14 | 1.01177258 |
| 50 | TBK1 | 1.00705274 |
| 51 | ICK | 1.00658758 |
| 52 | PRKAA2 | 0.99198028 |
| 53 | CSK | 0.99096150 |
| 54 | TIE1 | 0.98020060 |
| 55 | MAPK4 | 0.97533975 |
| 56 | NLK | 0.96839617 |
| 57 | PDGFRA | 0.96771192 |
| 58 | TAOK1 | 0.96688018 |
| 59 | FRK | 0.95630171 |
| 60 | MAP2K6 | 0.95444595 |
| 61 | ERBB2 | 0.92426200 |
| 62 | MAPK12 | 0.90921942 |
| 63 | FGR | 0.88765906 |
| 64 | SYK | 0.86926850 |
| 65 | STK38 | 0.85187160 |
| 66 | JAK1 | 0.85136050 |
| 67 | PINK1 | 0.83003889 |
| 68 | HIPK2 | 0.82854727 |
| 69 | FGFR3 | 0.82445011 |
| 70 | KSR2 | 0.80843459 |
| 71 | RET | 0.79893810 |
| 72 | EPHB1 | 0.79640651 |
| 73 | DAPK2 | 0.79216904 |
| 74 | MAP3K3 | 0.79075299 |
| 75 | PDGFRB | 0.78851452 |
| 76 | MYLK | 0.77465219 |
| 77 | LYN | 0.77024280 |
| 78 | CAMK1D | 0.76876716 |
| 79 | BLK | 0.74068191 |
| 80 | EPHA3 | 0.73661454 |
| 81 | PTK2B | 0.72272069 |
| 82 | CAMK4 | 0.71543041 |
| 83 | LCK | 0.70277239 |
| 84 | LRRK2 | 0.68659933 |
| 85 | MATK | 0.67344681 |
| 86 | PRKACG | 0.66948902 |
| 87 | GRK7 | 0.65939811 |
| 88 | PRKCZ | 0.65362752 |
| 89 | DYRK1B | 0.64748974 |
| 90 | FGFR2 | 0.64147048 |
| 91 | WNK1 | 0.63672392 |
| 92 | YES1 | 0.63025643 |
| 93 | CDK6 | 0.62722486 |
| 94 | STK38L | 0.59593047 |
| 95 | DDR2 | 0.59342952 |
| 96 | MAPK15 | 0.59022586 |
| 97 | GSK3A | 0.56487361 |
| 98 | RIPK1 | 0.55603278 |
| 99 | FER | 0.55398344 |
| 100 | IKBKE | 0.54572803 |
| 101 | IGF1R | 0.54416024 |
| 102 | EEF2K | 0.54199742 |
| 103 | RPS6KL1 | 0.54164747 |
| 104 | RPS6KC1 | 0.54164747 |
| 105 | MET | 0.53499145 |
| 106 | PRKAA1 | 0.53190008 |
| 107 | PRKG2 | 0.52214386 |
| 108 | PTK2 | 0.50004264 |
| 109 | MAP3K11 | 0.49188605 |
| 110 | RPS6KA2 | 0.48333664 |
| 111 | TAOK2 | 0.46867768 |
| 112 | AKT3 | 0.46178920 |
| 113 | KIT | 0.46017082 |
| 114 | TRPM7 | 0.45666259 |
| 115 | FYN | 0.44094260 |
| 116 | TTN | 0.44073743 |
| 117 | RPS6KA6 | 0.43853699 |
| 118 | PIK3CA | 0.42981856 |
| 119 | MOS | 0.42433211 |
| 120 | CDK4 | 0.42270574 |
| 121 | MARK3 | 0.41997359 |
| 122 | IRAK1 | 0.40053840 |
| 123 | IKBKB | 0.39875757 |
| 124 | SIK3 | 0.39589240 |
| 125 | PRKD1 | 0.38572513 |
| 126 | PRKCQ | 0.37718570 |
| 127 | STK10 | 0.37233913 |
| 128 | MTOR | 0.36805599 |
| 129 | CAMK2G | 0.36619712 |
| 130 | MAPKAPK2 | 0.36508534 |
| 131 | ZAP70 | 0.35321157 |
| 132 | MAP2K2 | 0.33095798 |
| 133 | IRAK2 | 0.30111458 |
| 134 | SGK3 | 0.29889462 |
| 135 | ABL1 | 0.28983564 |
| 136 | PDPK1 | 0.28868416 |
| 137 | MAP2K1 | 0.28731996 |
| 138 | EGFR | 0.28419151 |
| 139 | ITK | 0.26247445 |
| 140 | CHUK | 0.25751250 |
| 141 | MAP3K5 | 0.24748242 |
| 142 | PRKCD | 0.24733287 |
| 143 | PDK1 | 0.24335932 |
| 144 | MAP3K13 | 0.23269675 |
| 145 | MAPK3 | 0.23216850 |
| 146 | BTK | 0.22006459 |
| 147 | ADRBK1 | 0.20842807 |
| 148 | BMX | 0.20519511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53497597 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34715985 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31753464 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17958327 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93794068 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85419009 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71931198 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61244046 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57979141 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55195481 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47314421 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45249896 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42833450 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.11456140 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10712157 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.05674879 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04513609 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01047406 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93245546 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90074246 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89494748 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86267530 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85425424 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78124376 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74728396 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73480003 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71759386 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70237402 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66639709 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65428782 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58068552 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49585028 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49028195 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48073326 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44833704 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.43697299 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40827386 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38599183 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.36322387 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34371026 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33840656 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31850256 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.31036305 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29691135 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28115599 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27405968 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.20813166 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19552445 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16404744 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16188072 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.15789457 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10470604 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.07481897 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02550991 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00965257 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99312317 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98990413 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93620125 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93603911 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90384772 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.86538220 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82810587 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82518449 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79322561 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.79139477 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78996200 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.78337815 |
| 68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75451114 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74509606 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74114866 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72892272 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71761039 |
| 73 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71523183 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70945289 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70389644 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68402542 |
| 77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68103691 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66274084 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65984304 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63149297 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.62353520 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61291649 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58650875 |
| 84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58625442 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.56443192 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.55848619 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54228928 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53721319 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52913873 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.52909230 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51867887 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50995767 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.49221177 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48608904 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48545956 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46635799 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45651290 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45067588 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43728342 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42668903 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41885526 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41462237 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41068343 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40778319 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39228043 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37073861 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36470988 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36147432 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.35872879 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.35767500 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35263364 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34502440 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32090171 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31738042 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.28290103 |
| 116 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27340967 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27066254 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.22397414 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22372865 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17902474 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.09944329 |
| 122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08219758 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07962335 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02137786 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01259626 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00500788 |
| 127 | Lysosome_Homo sapiens_hsa04142 | -0.2228841 |
| 128 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2198397 |
| 129 | Pertussis_Homo sapiens_hsa05133 | -0.2082876 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1812572 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1784200 |
| 132 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1756496 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1589359 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1519857 |
| 135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1475294 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1392840 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | -0.1362660 |
| 138 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1105860 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0861158 |
| 140 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0765881 |
| 141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0723013 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0515974 |
| 143 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0462540 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0005326 |

